Treatment and Prevention of Major Adverse Cardiovascular Events or Major Coronary Events by Administering Omega-3 Fatty Acids
GB0612845D0
Process for reducing the free fatty acid content of natural oils using a selectively permeable membrane
CN103058867A
Novel DHA derivatives for and uses thereof as medicament
WO2006077495A1
Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-rerelated diseases
JP2006077016A
TREATMENT OF IgA NEPHROPATHY USING OMEGA-GA-3 FATTY ACID
CN102861004A
Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
WO2004056370A1
Use of a fatty acid composition for treatment of male infertility
US2006148047A1
Lipase-catalysed esterification of marine oil
NZ548508A
Use of EPA and DHA in preventing cerebral damage wherein the dosage ranges from 0.5 to 5.0g of EPA and/or DHA daily
